The Chan Soon-Shiong Windber Institute of Molecular Medicine Established with the Integration of Windber Medical Center and Windber Research Institute

The Chan Soon-Shiong Windber Institute of Molecular Medicine Established with the Integration of Windber Medical Center and Windber Research Institute

August 14, 2015 07:00 AM Eastern Daylight Time

WINDBER, Pa. & CULVER CITY, Calif.--()--Windber Medical Center (WMC) and Windber Research Institute (WRI) have entered into definitive agreements with the Chan Soon-Shiong Institute of Molecular Medicine, (CSSIOMM), a nonprofit medical research organization founded by Dr. Patrick Soon-Shiong and his wife, Michele Chan, to establish an integrated community based health care organization delivering 21st century care.

The agreements include the creation of a precision cancer research and treatment institute at WMC and WRI. The vision for WMC and WRI is to become dedicated molecular medicine and genomic research institutions and centers of excellence for studying cancer and other diseases. WMC and WRI will remain non-profit institutions with WMC continuing its mission as an acute care community hospital and retaining its existing service lines. Regional and national clinical delivery partnerships with major health systems are under discussion.

"Dr. Soon-Shiong is a visionary at the forefront of transforming health care in the U.S. and around the world through research, technology and integrated communication," said Tom Kurtz, CEO of WMC and WRI. "Importantly, the transaction will align WMC and WRI with NantWorks, an ecosystem of companies founded by Dr. Soon-Shiong to revolutionize health care and other industries with improvements in science, technology and communication. Joining forces with CSSIOMM will allow us to expand our footprint and change lives for the better in our community here in Pennsylvania as well as across the nation."

"The transaction will enable WMC and WRI to not only grow but serve as the perfect platform for translating cutting edge medical science into the clinical setting at the local community level," said Dr. Soon-Shiong. "CSSIOMM's expertise, resources and reach, combined with WRI's state of the art tissue bank and DNA and RNA extraction capabilities, furthers the stated mission of our respective organizations, which is to engage in advanced medical care and pioneering medical research for the benefit of patients. It is important to our mission to support local community care and the 30 bed hospital at Windber is an important resource that must be protected."

In 2014, CSSIOMM partnered with the University of Oxford to establish the Chan Soon-Shiong Center for Genomic and Proteomic medicine for cancer patients in the United Kingdom. That same year, CSSIOMM established The Chan Soon-Shiong Children's Precision Medicine Institute at Phoenix Children's Hospital, where state-of-the-art genomic and proteomic technologies are applied to identify precision diagnoses, treatments and cures for young patients facing serious illnesses.

About The Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM)

Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM) is a division of the Chan Soon-Shiong NantHealth Foundation, a 501(c)(3) non-profit medical research organization focused on transforming medical practice by facilitating digital molecular diagnosis. CSSIOMM is building a coalition dedicated to collaborating with health care, academic, government, and private sector partners to enable evidence based and molecularly driven, clinical decisions. The mission of CSSIOMM is to facilitate transformation of health systems to focus on health not just healthcare, to create a culture of caring and to support the development of next generation clinical scientists. The goal of the CSSIOMM is to improve the lives of the people and to enable sustainable health systems for the future.

About Windber Research Institute

Windber Research Institute (WRI) is a private, non-profit biomedical research institute established in 2000 with two distinct but complementary programs: Translational Research and Health Promotion/Disease Prevention. The research programs include breast cancer research and cardiovascular disease research. State-of-the-art laboratories in Genomics and Cell Biology are supported by a robust Biorepository and a Biomedical Informatics Program. The Biorepository manages the collection, processing, storage and distribution of all biospecimens for research. The Biomedical Informatics Program provides data analysis and manages a data warehouse that stores patient clinical and demographic data which is integrated with research data. Translational Research at WRI has strong clinical input from its partners at the Walter Reed National Military Medical Center in Bethesda, Maryland.

About Windber Medical Center

Windber Medical Center is a nonprofit, community healthcare provider dedicated to providing excellence in personalized, quality healthcare services through innovation, research and education in response to community needs. The general medical and surgical hospital is located in Windber, PA.

Contacts

Media Contact
NantWorks
Jen Hodson, 562-397-3639
[email protected]

 

 

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.